10:10 AM EST - Acerus Pharmaceuticals Corporation : Announced that, effective July 1, an additional leading pharmacy benefit manager (PBM) in the United States has elected to make NATESTO® (testosterone nasal gel) a “Preferred Brand” on its National Preferred Drug List. Acerus Pharmaceuticals Corporation
shares T.ASP are trading up $0.005 at $0.05.
